Therapeutic potential of carbon monoxide in multiple sclerosis

Clinical and Experimental Immunology

Volumn 167, Issue 2, 2012, Pages 179-187

  Fagone, P ^a   Mangano, K ^a   Coco, M ^a   Perciavalle, V ^a   Garotta, G ^b   Romao, C C ^c   Nicoletti, F ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Alfama   (Portugal)

^c INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

Carbon monoxide; CORMs; Haem oxygenase; Multiple sclerosis

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE; HEME OXYGENASE 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; CLINICAL EFFECTIVENESS; DISEASE DURATION; DRUG EFFICACY; ENCEPHALOMYELITIS; HUMAN; IMMUNOMODULATION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNITY; BORANES; CARBON MONOXIDE; CARBONATES; CARDIOTONIC AGENTS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GUANYLATE CYCLASE; HEME; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROIMMUNOMODULATION; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

EID: 84855798185     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04491.x     Document Type: Review

References (89)

1. Sjoestrand T. Endogenous formation of carbon monoxide in man. Nature 1949; 164:580.
2. Landaw SA, Callahan EW, Schmid R. Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide. J Clin Invest 1970; 49:914-25.
3. Coburn RF, Williams WJ, Forster RE. Effect of erythrocyte destruction on carbon monoxide production in man. J Clin Invest 1965; 43:1098-103.
4. Yachie A, Niida Y, Wada T etal. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103:129-35.
5. Mizuguchi S, Stephen J, Bihari R etal. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase. Am J Physiol Heart Circ Physiol 2009; 297:H920-9.
6. Ferrándiz ML, Maicas N, Garcia-Arnandis I etal. Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis. Ann Rheum Dis 2008; 67:1211-17.
7. Takagi T, Naito Y, Inoue M etal. Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1. Inflammation 2009; 32:83-8.
8. Takagi T, Naito Y, Mizushima K etal. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-α expression. Dig Dis Sci 2010; 55:2797-804.
9. Chen P, Sun B, Chen H etal. Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats. Cytokine 2010; 49:15-23.
10. Hoetzel A, Schmidt R, Vallbracht S etal. Carbon monoxide prevents ventilator-induced lung injury via caveolin-1. Crit Care Med 2009; 37:1708-15.
11. Otterbein LE, Zuckerbraun BS, Haga M etal. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9:183-90.
12. Foresti R, Bani-Hani MG, Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intens Care Med 2008; 34:649-58.
13. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010; 9:728-43.
14. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical applications. FASEB J 1988; 2:2557-68.
15. Tyrrell R. Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res 1999; 31:335-40.
16. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG. Identification of binding sites for transcription factors NF-B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 1994; 91:5987-91.
17. Sato M, Ishizawa S, Yoshida T, Shibahara S. Interaction of upstream stimulatory factor with the human heme oxygenase gene promoter. Eur J Biochem 1990; 188:231-7.
18. Tyrrell RM, Applegate LA, Tromvoukis Y. The proximal promoter region of the human heme oxygenase gene contains elements involved in stimulation of transcriptional activity by a variety of agents including oxidants. Carcinogenesis 1993; 14:761-5.
19. Sardana MK, Drummond GS, Sassa S, Kappas A. The potent heme oxygenase inducing action of arsenic and parasiticidal arsenicals. Pharmacology 1981; 23:247-53.
20. Wu L. The pro-oxidant role of methylglyoxal in mesenteric artery smooth muscle cells. Can J Physiol Pharmacol 2005; 83:63-8.
21. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000; 28:1303-12.
22. Nath KA, Grande JP, Haggard JJ etal. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 2001; 158:893-903.
23. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 1997; 100:589-96.
24. Ndisang JF, Wang R. Age-related alterations in soluble guanylyl cyclase and cGMP pathway in spontaneously hypertensive rats. J Hypertens 2003; 21:1117-24.
25. Carraway MS, Ghio AJ, Suliman HB, Carter JD, Whorton AR, Piantadosi CA. Carbon monoxide promotes hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2002; 282:L693-L702.
26. Durante W, Christodoulides N, Cheng K, Peyton KJ, Sunahara RK, Schafer AI. cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am J Physiol 1997; 273:H317-23.
27. Terry CM, Clikeman JA, Hoidal JR, Callahan KS. TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+ and phospholipase A2 in endothelial cells. Am J Physiol 1999; 276:H1493-H1501.
28. Elbirt KK, Whitmarsh AJ, Davis RJ, Bonkovsky HL. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J Biol Chem 1998; 273:8922-31.
29. Alam J, Wicks C, Stewart D etal. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem 2000; 275:27694-702.
30. Chen K, Maines MD. Nitric oxide induces heme oxygenase-1 via mitogen activated protein kinases ERK and p38. Cell Mol Biol 2000; 46:609-17.
31. Furchgott RF, Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991; 28:52-61.
32. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92:1475-9.
33. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 1997; 272:32804-9.
34. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science 1993; 259:381-4.
35. Otterbein LE, Bach FH, Alam J etal. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6:422-8.
36. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8:240-6.
37. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94:10925-30.
38. Wagener FA, Volk H, Willis D etal. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003; 55:551-71.
39. Hayashi S, Takamiya R, Yamaguchi T etal. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 1999; 85:663-71.
40. Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AMK. Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 2002; 27:739-45.
41. Pae HO, Oh GS, Choi BM etal. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172:4744-51.
42. Ryter SW, Otterbein LE. Carbon monoxide in biology and medicine. BioEssays 2004; 26:270-80.
43. Vera T, Henegar JR, Drummond HA, Rimoldi JM, Stec DE. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 2005; 16:950-8.
44. Ryan MJ, Jernigan NL, Drummond HA etal. Renal vascular responses to CORM-A1 in the mouse. Pharmacol Res 2006; 54:24-9.
45. Foresti R, Hammad J, Clark JE etal. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 2004; 142:453-60.
46. Clark JE, Naughton P, Shurey S etal. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93:e2-e8.
47. Musameh MD, Fuller BJ, Mann BE, Green CJ, Motterlini R. Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart. Br J Pharmacol 2006; 149:1104-12.
48. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 2005; 145:800-10.
49. Bani-Hani MG, Greenstein D, Mann BE, Green CJ, Motterlini R. Modulation of thrombin-induced neuroinflammation in BV-2 microglia by a carbon monoxide-releasing molecule (CORM-3). J Pharmacol Exp Ther 2006; 318:1315-22.
50. Freitas A, Alves-Filho JC, Secco DD etal. Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol 2006; 149:345-54.
51. Vannacci A, Giannini L, Fabrizi F etal. Effects of the carbon monoxide releasing molecule CORM-3 in a coincubation model of rat mast cells with human neutrophils. Inflamm Res 2007; 56:S13-S14.
52. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc Res 2006; 71:393-401.
53. Parfenova H, Basuroy S, Bhattacharya S etal. Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am J Physiol Cell Physiol 2005; 290:C1399-C1410.
54. Li MH, Cha YN, Surh YJ. Carbon monoxide protects PC12 cells from peroxynitrite-induced apoptotic death by preventing the depolarization of mitochondrial transmembrane potential. Biochem Biophys Res Commun 2006; 342:984-90.
55. Sun BW, Chen ZY, Chen X, Liu C. Attenuation of leukocytes sequestration by carbon monoxide-releasing molecules: liberated carbon monoxide in the liver of thermally injured mice. J Burn Care Res 2007; 28:173-81.
56. Allanson M, Reeve VE. Carbon monoxide signalling reduces photocarcinogenesis in the hairless mouse. Cancer Immunol Immunother 2007; 56:1807-15.
57. Sandouka A, Fuller BJ, Mann BE, Green CJ, Foresti R, Motterlini R. Treatment with carbon monoxide releasing molecules (CO-RMs) during cold storage improves renal function at reperfusion. Kidney Int 2006; 69:239-47.
58. Tayem Y, Johnson TR, Mann BE, Green CJ, Motterlini R. Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am J Physiol Renal Physiol 2006; 290:F789-F794.
59. Dwyer BE, Nishimura RN, Lu SY. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res 1995; 30:37-47.
60. Panahian N, Yoshiura M, Maines MD. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 1999; 72:1187-203.
61. Fukuda K, Richmon JD, Sato M, Sharp FR, Panter SS, Noble LJ. Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain injury. Brain Res 1996; 736:68-75.
62. Premkumar DR, Smith MA, Richey PL etal. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 1995; 65:1399-402.
63. Takahashi M, Dore S, Ferris CD etal. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 2000; 28:461-73.
64. Schipper HM, Chertkow H, Mehindate K, Frankel D, Melmed C, Bergman H. Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 2000; 54:1297-304.
65. Yoo MS, Chun HS, Son JJ etal. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 2003; 110:76-84.
66. Smith KJ, Kapoor R, Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999; 9:69-92.
67. Pinteaux E, Perraut M, Tholey G. Distribution of mitochondrial manganese superoxide dismutase among rat glial cells in culture. Glia 1998; 22:408-14.
68. Ruuls SR, Bauer J, Sontrop K, Huitinga I, 't Hart BA, Dijkstra CD. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1995; 56:207-17.
69. Toshniwal PK, Zarling EJ. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem Res 1992; 17:205-7.
70. Dallas ML, Boyle JP, Milligan CJ etal. Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1. FASEB J 2011; 25:1519-30.
71. Stahnke T, Stadelmann C, Netzler A, Brück W, Richter-Landsberg C. Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci 2007; 32:25-37.
72. Fugger L, Friese MA, Bell JI. From genes to function: the next challenge to understanding multiple sclerosis. Nat Rev Immunol 2009; 9:408-17.
73. Nicoletti F, Di Marco R, Patti F etal. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha. Cytokine 2000; 12:682-7.
74. Nicoletti F, Di Marco R, Patti F etal. Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). Clin Exp Immunol 1998; 113:96-9.
75. Nicoletti F, Patti F, DiMarco R etal. Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine 1996; 8:395-400.
76. Emerson MR, Gallagher RJ, Marquis JG, LeVine SM. Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design. Comp Med 2009; 59:112-28.
77. Schipper HM. Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 2004; 37:1995-2011.
78. Liu Y, Zhu B, Luo L, Li P, Paty DW, Cynader MS. Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. Neuroreport 2001; 12:1841-5.
79. Chora AA, Fontoura P, Cunha A etal. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 2007; 117:438-47.
80. Lin Y, Vreman HJ, Wong RJ, Tjoa T, Yamauchi T, Noble-Haeusslein LJ. Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord. J Cereb Blood Flow Metab 2007; 27:1010-21.
81. Fagone P, Mangano K, Quattrocchi C etal. Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. Clin Exp Immunol 2011; 163:368-74.
82. Pamplona A, Ferreira A, Balla J etal. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 2007; 13:703-10.
83. Chakrabarty A, Emerson MR, LeVine SM. Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult Scler 2003; 9:372-81.
84. Stüve O, Youssef S, Slavin AJ etal. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J Immunol 2002; 169:6720-32.
85. Becher B, Bechmann I, Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 2006; 84:532-43.
86. Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002; 169:4712-16.
87. Bishop A, Yet SF, Lee ME, Perrella MA, Demple B. A key role for heme oxygenase-1 in nitric oxide resistance in murine motor and glia. Biochem Biophys Res Commun 2004; 325:3-9.
88. Hövelmeyer N, Hao Z, Kranidioti K etal. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol 2005; 175:5875-84.
89. Soares MP, Lin Y, Anrather J etal. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998; 4:1073-7.